Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-017372
Filing Date
2022-08-15
Accepted
2022-08-15 16:07:50
Documents
62
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alrn-20220630.htm   iXBRL 10-Q 1865626
2 EX-10.1 alrn-ex10_1.htm EX-10.1 115625
3 PDF COURTESY COPY alrn-ex10_1.pdf EX-10.1 163146
4 EX-31.1 alrn-ex31_1.htm EX-31.1 17126
5 EX-31.2 alrn-ex31_2.htm EX-31.2 16611
6 EX-32.1 alrn-ex32_1.htm EX-32.1 10778
7 EX-32.2 alrn-ex32_2.htm EX-32.2 9149
  Complete submission text file 0000950170-22-017372.txt   7045955

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alrn-20220630_cal.xml EX-101.CAL 33688
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alrn-20220630_lab.xml EX-101.LAB 364015
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alrn-20220630_pre.xml EX-101.PRE 253806
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alrn-20220630_def.xml EX-101.DEF 129604
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alrn-20220630.xsd EX-101.SCH 35752
56 EXTRACTED XBRL INSTANCE DOCUMENT alrn-20220630_htm.xml XML 1248640
Mailing Address 285 SUMMER STREET UNIT 101 BOSTON MA 02210
Business Address 285 SUMMER STREET UNIT 101 BOSTON MA 02210 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38130 | Film No.: 221165686
SIC: 2834 Pharmaceutical Preparations